Does CANAKINUMAB Cause Conjunctivitis? 29 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 29 reports of Conjunctivitis have been filed in association with CANAKINUMAB (Ilaris). This represents 0.3% of all adverse event reports for CANAKINUMAB.
29
Reports of Conjunctivitis with CANAKINUMAB
0.3%
of all CANAKINUMAB reports
0
Deaths
13
Hospitalizations
How Dangerous Is Conjunctivitis From CANAKINUMAB?
Of the 29 reports, 13 (44.8%) required hospitalization.
Is Conjunctivitis Listed in the Official Label?
Yes, Conjunctivitis is listed as a known adverse reaction in the official FDA drug label for CANAKINUMAB.
What Other Side Effects Does CANAKINUMAB Cause?
Pyrexia (1,327)
Inappropriate schedule of drug administration (1,238)
Drug ineffective (1,078)
Inappropriate schedule of product administration (944)
Pain (858)
Condition aggravated (771)
Malaise (684)
Off label use (557)
Arthralgia (555)
Rash (505)
What Other Drugs Cause Conjunctivitis?
DUPILUMAB (5,270)
ADALIMUMAB (457)
METHOTREXATE (385)
ETANERCEPT (306)
PREDNISONE (250)
SECUKINUMAB (237)
RITUXIMAB (222)
SULFAMETHOXAZOLE\TRIMETHOPRIM (218)
INFLIXIMAB (212)
LAMOTRIGINE (199)
Which CANAKINUMAB Alternatives Have Lower Conjunctivitis Risk?
CANAKINUMAB vs CANDESARTAN
CANAKINUMAB vs CANDESARTAN CILEXETIL
CANAKINUMAB vs CANDESARTAN CILEXETIL\HYDROCHLOROTHIAZIDE
CANAKINUMAB vs CANGRELOR
CANAKINUMAB vs CANIS LUPUS FAMILIARIS SKIN